In advance of the April 1, 2023, enforcement date for the new animal compounding guidance from FDA,...
Demonstrate your commitment to your patients and practice at APC’s annual DC fly-in for pharmacy compounders, September 17-18 at Hilton National Mall.
It’s 18 hours that can make a big difference for your compounding practice and patients.
On the agenda:
- Meet with your members of Congress. Show ’em you're concerned enough about your patients and practice to fly to DC to meet with them.
- Key issues include enhancing the FDA drug shortage list, eliminating the MOU in federal law, implementing adverse events reporting for 503As, and preserving compounded hormone therapy.
- Learn the latest from policymakers and influencers from FDA, Congress, and industry.
- Network with your fellow compounders. There's strength — and idea-sharing — in numbers.
NEW! Prior to kicking off CCH, we’re hosting APC's first ever three-hour Legal Issues in Compounding symposium. It's 7:30 – 11:30 am on Tuesday, September 17, a separately ticketed event including:
- Compounding legal update
- The Demonstrably Difficult to Compound list
- Peptide compounding, including GLP-1s
- Telemedicine compliance concerns
- Sourcing from 503Bs: best practices for 503As
- FDA inspections: recent actions and insights
Click here for info and to register — and we'll see you on the Hill!
